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Abstract: A detailed chemical investigation of the red resins from Dracaena cochinchinensis (Chinese dragon’s blood) yielded five 
new flavonoid oligomers, named cochinchinenins D–H (1–5), together with a known biflavonoid, cinnabarone (6), and a mixture of 
two known biflavonoids, socotrin-4'-ol (7) and homoisosocotrin-4'-ol (8). Of these new compounds, 1–3 were biflavonoids and 4 
and 5 were triflavonoids. Their structures were determined on the basis of spectroscopic analysis. The isolated compounds were 
tested for cytotoxicity (Cdc25), antibacterial (PEPT) and antifungal (YNG) activities. 
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Introduction 
The resins excreted from stems of several disparate taxa, i.e. 
Dracaena (Agavaceae), Croton (Euphorbiaceae), Pterocarpus 
(Leguminosa) and Daemonorops (Palmae), have been used 
traditionally from ancient times as dragon’s blood for the 
treatment of traumatic and visceral hemorrhages.1 In China, 
dragon’s blood has been imported and used traditionally as an 
important traditional Chinese medicinal herb for the treatment 
of traumatic and visceral hemorrhages since Tang dynasty.2 
Until 1970s, the red resin of Dracaena cochinchinensis S. C. 
Chen (Agavaceae) found in the southwest of China has been 
used widely as the substitute for the traditionally imported 
dragon’s blood.3 Chemical studies on the dragon’s blood from 
the genus Dracaena (D. draco, D. cinnabari and D. loureiri) 
have revealed the occurrence of flavonoids, including flavan, 
flavone, chalcones, homoisoflavanes, and the oligomers of 
flavonoids.4–16 Flavonoid oligomers, composing of one 
dihydrochalcone unit condensed with one or more chalcone, 
flavane or homoisoflavane units,5–7 constituted the major 
identified components of dragon’s blood from the genus 
Dracaena. Furthermore, a series of publications reported the 
natural product diversity of original plants of dragon’s blood 
from the genus Dracaena.17–28 These natural products from 
Dragon’s blood and its original plants showed cytotoxic, 
antibacterial, and antioxidant activities.15,29,30 
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Figure 1.  Compounds isolated from Chinese dragon’s blood, the 
red resins of Dracaena cochinchinensis 
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D. cochinchinensis S. C. Chen is an evergreen tree or shrub 
native to the tropical region of southwestern China, Myanmar, 
and Laos. The red resin excreted from the stems was originally 
used by the Dai people living in the southern part of Yunnan 
province, China, for the treatment of pain and hemorrhages. 
From 1970s, it has been used widely as the main source of 
dragon’s blood, called Long-Xue-Jie (Chinese dragon’s blood), 
for the treatment of traumatic and visceral hemorrhages.3 
Previous studies showed that the resin contains mainly of 
phenolic compounds, as well as several steroids and aliphatic 
acids.30–38 
In our continuing studies on Chinese dragon’s blood, five 
new flavonoid oligomers namely cochinchinenins D–H (1–5) 
were further isolated and identified from the red resin of D. 
cochinchinesis, in addition to the known biflavonoid,  
cinnabarone (6), and a mixture of two known biflavonoids, 
socotrin-4'-ol (7) and homoisosocotrin-4'-ol (8). Their  
structures were elucidated on the basis of detailed spectroscopic
analysis. The cytotoxicity (CDC25), antibacterial (PEPT) and 
antifungal (YNG) activities of the isolated compounds 1–8 
were also evaluated. 
 
Results and Discussion 
The CHCl3 extract of the red resin from D. cochinchinensis 
was subjected to a silica gel column and eluted with 
CHCl3/MeOH. Six fractions were yielded. Fractions 1–4  
contained mainly simple flavonoids.30 Further detailed study 
on fractions 5 and 6 led to the identification of eight flavonoid 
oligomers (1–8). Of these, 6 was the known biflavonoid,  
cinnabarone,8 while 7 and 8 were obtained as a mixture of two 
known biflavonoids, socotrin-4'-ol (7)7 and homoisosocotrin-
4'-ol (8).7 The known compounds (6–8) were elucidated by 
comparison of their spectroscopic data with the reported  
literature values. 
Compound 1 was obtained as a brown amorphous powder 
and had a molecular formula C33H34O7, as deduced by the 
positive ion HRESIMS (m/z 542.2261 [M]+) and the 13C NMR 
(Table 1), implying 17 degrees of unsaturation. All 33 carbon 
resonances were well resolved in the 13C NMR spectrum  
(Table 1) and further classified by DEPT and HSQC  
experiments as 13 quaternary aromatic carbons with seven 
bearing oxygen, 13 methines with 11 aromatic carbons, four 
aliphatic methylenes, one shielded methyl (δ 9.1) and two 
methoxys (δ 55.6 and 56.4). The aromatic region of the 1H 
NMR spectrum of 1 displayed two two-proton doublets [δ 7.10 
and 6.70 (each 2H, J = 8.6 Hz)] arising from a 1,4-
disubstituted benzene ring. In addition, two sets of ABX  
coupled signals were ascribable to two 1,2,4-trisubstituted 
aromatic rings, and one-proton singlet (δ 6.75) was due to a 
pentasubstituted aromatic ring. Moreover, 19 aliphatic protons 
arising from four CH2, two CH, one CH3 (δ 2.03, s) and two 
OCH3 (δ 3.75, 3.83, each s) were observed. These aforemen-
tioned 1H NMR data of 1 were similar to those of socotrin-4'-
ol (7),3 except for the substitutions of rings A and B, and the 
appearance of two additional methyl groups in 1. One of the 
methyls was a methoxy at an aromatic ring (δ 56.4), while the 
other (δ 9.1) was linked to an aromatic ring directly. 
Detailed analysis of the 1H-1H COSY, HSQC, and HMBC 
spectra (Figure 1) revealed that 1 was a biflavonoid composed 
of a deoxotetrahydrochalcone unit and a flavan unit. Firstly, 
HSQC correlations led to the assignments of the protons to 
their corresponding carbons. The long-range correlations  
observed in the HMBC spectrum enabled the assignments of 
each proton and carbon signal of the four aromatic rings and 
the connection between these substructures, as shown in 1 
(Figure 2). In the HMBC spectrum, the correlation of  
oxygen-bearing methine proton at δ 4.91 (H-2) with aromatic 
carbons at δ 135.5 (C-1'), 110.8 (C-2') and 119.7 (C-6')  
indicated the 1,3,4-trisubstituted aromatic ring as B ring. The 
aromatic ring was further confirmed to be 3'-methoxy-4'-
hydroxy substitution by HMBC cross peaks of H-2' with  
C-6'/C-4', H-5' with C-3'/C-1', H-6' with C-2'/C-4', as well as 
of the methoxy protons at δ 3.83 (s) with C-3'. Correlations of 
the methylene protons at δ 2.48 (2H, H-β) were observed with 
aromatic carbons at δ 160.0 (C-2'') and 131.1(C-6''). The  
corresponding protons at δ 6.85 (d, J = 8.0 Hz), 6.29 (dd, J = 
8.0, 2.3 Hz) and 6.39 (d, J = 2.3 Hz) indicated that D-ring was 
a 1,2,4-trisubstituted aromatic ring, on which a hydroxy and a 
methoxy group were linked at C-4'' and C-2'', respectively. 
This was confirmed by the cross peak from the methoxy  
proton at δ 3.75 and C-2'' (δ 160.0). Moreover, HMBC  
correlations of the CH proton at δ 4.24 with aromatic carbons 
at δ 130.5 (C-2'" and 6'"), 152.5 (C-7) and 126.0 (C-5)  
revealed that the E ring was a 1,4-disubsitututed aromatic ring 
with a hydroxyl group at C-4'", and the A ring was a pentasub-
stituted aromatic ring with a hydroxyl group and methyl at C-7 
and C-8, respectively. This assignment was confirmed by the 
HMBC correlations of H-5 with δ 152.5 (C-7)/153.1 (C-8a), 
and CH3 (δ 2.03) with δ 112.6 (C-8)/152.5 (C-7)/153.1 (C-8a). 
Therefore, the structure of cochinchinenin D was determined 
as shown in Figure 1. 
The molecular formula of compound 2 was assigned as 
C33H34O6 on the basis of its 13C NMR data (Table 1) and  
positive HRESIMS, which was 14 Da heavier than that of 
homoisosocotrin-4'-ol (8).3 The 1H and 13C NMR data of 2 
were very similar to those of 8, except for an additional oxygen-
bearing methyl group, indicating that 2 was a methyl ether of 8. 
The position of the additional methoxy group in 2 was  
revealed to be at C-4" by the HMBC correlation of a methoxy 
group at δ 3.53 with an oxygen-bearing aromatic carbon at δ 
159.5 (C-4"). Other HMBC and 1H-1H COSY correlations 
(Electronic Supplementary Material) confirmed the structure 
of 2. Accordingly, compound 2 was deduced to be the 4"-
methyl ether of homoisosocotrin-4'-ol, and named 
cochinchinenin E. 
  
Figure 2.  1H-1H COSY and selected HMBC correlations of 1
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Compound 3 was a brown amorphous powder and showed a 
molecular ion peak in its positive ion HRESIMS corresponding
to the molecular formula C33H34O7, which was 14 mass units 
more than that of cinnabarone (6).8 The 1H and 13C NMR  
spectra (Table 1) of 3 were closely related to those of 6,8 except
for an additional oxidized methyl group, indicating that 3 was 
a methyl ether of 6. Careful comparison of the NMR data of 3 
with those of 6 showed that the signal assigned to C-4' was 
deshielded to δ 165.2 (from δ 163.6 in 6), while the other  
signals were quite similar with each other. These revealed that 
the C-4' of compound 3 was substituted by a methoxyl group 
relative to 6. The HMBC and 1H-1H COSY correlations  
(Electronic Supplementary Material) further confirmed the 
structure of 3. Thus, cochinchinenin F was characterized as the 
4'-methyl ether of cinnabarone, as shown in Figure 1. 
The molecular formula of compound 4 was deduced as 
C49H50O9, on the basis of its negative ion HRFABMS and its 
NMR spectroscopic data. The 13C NMR spectrum of 4 showed 
the presence of 49 carbon signals, including 18 quaternary 
with nine oxygen-bearing ones, 18 tertiary sp2 carbons,  
ascribable to six aromatic rings, as well as 13 aliphatic carbons 
comprising six methylenes [δ 31.6 (CH2), 26.2 (CH2), 37.3 
(CH2  2) and 29.7 (CH2  2)], three methines [δ 78.8 (CH) 
and 43.2 (CH  2)], three methoxys [δ 55.6 (OCH3  2 ) and 
55.8 (OCH3)] and one methyl [δ 9.1 (CH3)]. Among them, the 
shielded methyl carbon at δ 9.1 suggested it was connected 
directly to a phenyl group. The 1H NMR spectrum displayed 
27 aliphatic protons including three singlets at δ 3.72 (6H), 　
3.68 (3H), and 1.90 (3H) assignable to three methoxys and one 
methyl, two multiplets at δ 4.65 (1H) and 4.20 (2H) and 18 
aromatic protons. These data indicated that 4 contained one 
flavane and two deoxotetrahydrochalcone units. Comparison 
of its NMR signals with those of damalchawin (9) suggested 
that both compounds had similar skeletons with different  
substitutions.5 Compound 4 had one methoxy, one methyl and 
one hydroxy group more than 9. On the basis of detailed  
analysis of the 1H-1H COSY experiment (Electronic  
Supplementary Material), the aromatic signals were distributed 
into three 1,4-disubstituted (three A2B2 spin systems, B, E and 
G rings), two 1,2,4,5-tetrasubstituted (four singlets, A and D 
rings) and one 1,2,3,4-tetrasubstituted (an AB spin system at δ 
6.24 and 6.72, F ring) aromatic rings. The long-range connec-
tivity observed in the HMBC spectrum enabled the connection  
between these aromatic substructures as shown in structure 4 
(Electronic Supplementary Material). The two CH protons 
showed correlations to two A2B2 spin systems (E, G rings), 
respectively. The H-β and H-β' (δ 2.42) signals showed  
correlations to one 1,2,4,5-tetrasubstituted aromatic ring (D 
ring) and an AB spin system (F ring). In the EIMS of 4 (Figure 
3), diagnostic fragments were detected at m/z 286 (4a), 256 
(4b), 242 (4c) [splitting into three monomers], 137 [benzyl 
cleavage], and a base peak at m/z 120 [benzyl cleavage], 
which clarified the subunits of the triflavonoid (Figure 2) and 
further confirmed the structure of cochinchinenin G as shown 
in Figure 1. 
Table 1. NMR spectroscopic data [100 (13C) and 400 (1H) MHz, CD3OD] for compounds 1–3 
 
position 
1 2 3 
C                                H (J in Hz) C H (J in Hz) C                        H (J in Hz) 
1  123.2 (C) 
2 79.2 (CH) 4.91, m 70.7 (CH2) 4.03, m; 3.82, m 155.9 (C) 
3 32.0 (CH2) 2.46, m; 2.11, m 30.0 (CH) 2.11, m 99.7 (CH) 6.36, s 
4 26.5 (CH2) 2.86, m; 2.66, m 31.4 (CH2) 2.86, m; 2.66, m 157.5 (C) 
4a 113.4 (C) 113.3 (C) 
5 126.0 (CH) 6.75, s 129.6 (CH) 6.56, s 120.7 (C) 
6 126.6 (C) 125.9 (C) 130.1 (CH) 6.90, s 
7 152.5 (C) 154.6 (C) 
8 112.6 (C) 103.3 (CH) 6.02, s 
8a 153.1 (C) 155.2 
9 37.9 (CH2) 2.30, m 
1' 135.5 (C) 131.7 (C) 138.3 (C) 
2' 110.8 (CH) 7.01, d (1.8) 129.6 (CH) 6.79, d (8.6) 131.7 (CH) 7.85, d (6.8) 
3' 148.9 (C) 116.0 (CH) 6.58, d (8.6) 115.7 (CH) 6.80, d (6.8) 
4' 146.9 (C) 157.3 (C) 165.2 (C) 
5' 116.0 (CH) 6.83, d (8.0) 116.0 (CH) 6.58, d (8.6) 115.7 (CH) 6.80, d (6.8)
6' 119.7 (CH) 6.92, dd (8.0, 1.8) 129.6 (CH) 6.79, d (8.6) 131.7 (CH) 7.85, d (6.8) 
1'' 123.3 (C) 131.6 (C) 124.8 (C) 
2'' 160.0 (C) 158.7 (C) 159.7 (C) 
3'' 99.8 (CH) 6.39, d (2.3) 99.5 (CH) 6.35, d (2.3) 99.8 (CH) 6.39, br. s 
4'' 157.6 (C) 159.5 (C) 157.5 (C) 
5'' 107.6 (CH) 6.29, dd (8.0,2.3) 107.3 (CH) 6.25, dd (2.3, 8.1) 107.5 (CH) 6.28, dd (7.9, 2.4) 
6'' 131.1 (CH) 6.85, d (8.0) 130.9 (CH) 6.80, d (8.1) 131.1 (CH) 6.83, d (7.9) 
 37.8 (CH2) 2.14, m 37.0 (CH2) 2.14, m 40.0 (CH2) 3.11, m 
 30.0 (CH2) 2.48, m 29.4 (CH2) 2.48, m 27.3 (CH2) 2.88, m 
C     202.2 (C) 
CH 44.1 (CH) 4.24, t (7.6) 43.0 (CH) 4.24, t (7.6) 43.1 (CH) 4.17, t (7.9) 
' 37.2 (CH2) 2.06, m 
'   29.5 (CH2) 2.38, m 
1"' 138.7 (CH) 139.1 (C) 130.1 (C) 
2"',6"' 130.5 (CH) 7.10, d (8.6) 129.8 (CH) 6.97, d (8.6) 130.0 (CH) 7.06, d (7.0) 
3"',5"' 116.2 (CH) 6.70, d (8.6) 114.2 (CH) 6.55, d (8.6) 115.7 (CH) 6.66, d (7.0) 
4"' 156.5 (C) 157.3 (C) 155.1 (C) 
CH3 9.1 (CH3) 2.03, s   
OCH3 55.6 (CH3) 3.75, s 55.4 (CH3) 3.54, s 55.6 (CH3) 3.75, s 
OCH3 56.4 (CH3) 3.83, s 55.4 (CH3) 3.53, s 55.7 (CH3) 3.75, s 
OCH3 55.9 (CH3) 3.81, s 
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Cochinchinenin H (5), a brown amorphous powder,  
possessed a molecular formula C50H52O10, as deduced from the 
negative ion HRFABMS and the NMR spectroscopic data, 
implying 25 unsaturated degrees. The 13C NMR spectrum of 5 
displayed the presence of 50 carbon signals, including one 
carbonyl (δ 202.0), 17 quaternary with nine bearing oxygen, 
and 19 tertiary sp2 carbons. These data suggested the existence 
of six benzene rings, in addition to 13 sp3 carbons. The 1H 
NMR spectrum showed 19 aromatic and 29 aliphatic protons. 
These NMR data suggested compound 5 was a triflavonoid 
composing of one dihydrochalcone and two deoxotetrahydro-
chalcone units. From a detailed analysis of the 1H-1H COSY 
and HSQC correlations (Electronic Supplementary Material), 
the aromatic signals were arranged to three 1,4-disubstituted 
(three A2B2 spin system, B, D, and F rings), two 1,2,4,5-
tetrasubstituted (four singlets, A and C rings) and one 1,2,4-
trisubstituted (an ABX spin system, E ring) aromatic rings, 
whereas the aliphatic protons were ascribable to five methoxys 
[δ 3.72 (3H), 3.68 (9H), 3.64 (3H)], two methines [δ 4.18 (2H, 
m)], and six methylenes. In the HMBC spectrum of 5, correla-
tions of the two CH protons (δ 4.18, m, 2H) with two A2B2 
spin systems (D and F rings) and two 1,2,4,5-tetrasubstituted 
(A and C rings) were observed (Electronic Supplementary 
Material). The HMBC correlations of H-β (δ 2.86, m) with the 
A ring carbons [δ 123.2 (C-1), C-2 (157.3), 131.2 (C-6)] and 
the carbonyl at δ 202.0 further confirmed the connection of 
dihydrochalcone unit and one deoxotetrahydrochalcone unit. 
Moreover, the HMBC correlations of H-β' (δ 2.38, m) with δ 
157.5 (C-2'') and 131.2 (C-6'') from the C ring, and H-β'' (δ 
2.38, m) with δ 158.9 (C-2''''') and 132.0 (C-6''''') of the E ring 
indicated the connection of an additional deoxotetrahydrochal-
cone unit. The oxidized methyl groups δ 3.72, 3.68 and 3.64 
showed cross peaks with carbon atoms δ 165.1 (C-4'), 157.3 
(C-2), 157.5 (C-2''), 159.7 (C-4'''''), 158.9 (C-2'''''), respectively, 
indicating the position of these groups. Thus, the structure of 
cochinchinenin H (5) was clarified as shown in Figure 1. 
Flavonoids have been found to be characteristic components 
in dragon’s blood from the genus Dracaena. Though some 
flavans, flavones, chalcones and homoisoflavanes were reported
from the red resin, only 12 biflavonoids (cinnabarone, 
2'-methoxy-socotrin-5'-ol, socotrin-4'-ol, homoisosocotrin-4'-ol,
cochinchinenin, cochinchinenenes A–D, (2R)-8-methyl-
socotrin-4'-ol, cochinchinenins B and C) and one triflavonoid 
(damalachawin) were identified as flavonoid oligomers.5,7,30,32 
The present study led to the further identification of three new 
biflavonoids (1–3) and two new triflavonoids (4 and 5) from 
the red resin of D. cochinchinensis. 
 
Experimental Section 
General Experimental Procedures. NMR spectra were run 
on Bruker AV-400 (for 1H and 13C NMR) and DRX-500 (for 
2D NMR) instruments with TMS as internal standard; Mass 
spectra were recorded on a VG Auto Spec-3000 or API 
QSTAR Pulsar-I spectrometers. UV spectra were obtained on 
a Shimadzu double-beam 210A spectrophotometer. Silica gel 
(200–300 mesh and 10–40 m), RP-18 (40–63 m) and  
Sephadex LH-20 were used for column chromatography. 
 
Plant Material. The red resin of D. cochinchinensis was 
purchased from Weihe Pharmaceutical Company (Yuxi,  
Table 2. NMR spectroscopic data [100 (13C) and 400 (1H) 




C                  H (J in Hz) C                       H (J in Hz)
1  123.2 (C)  
2 78.8 (CH) 4.65, m 157.3 (C)  
3 26.2 (CH2) 2.42, m 99.7 (CH) 6.34, s 
4 31.6 (CH2) 2.70, m 155.9 (C)  
4a 113.5 (C)    
5 129.6 (CH) 6.77, s 120.7 (C)  
6 126.6 (C)  131.2 (CH) 6.80, s 
7 156.0 (C)    
8 107.5 (CH) 6.68, s  
8a 154.6 (C)    
1' 134.8 (C)  138.4 (C)  
2',6' 128.3 (CH) 7.07, d (8.6) 131.7 (CH) 7.80, d (8.5)
3',5' 114.4 (CH) 6.68, d (8.6) 115.7 (CH) 6.80, d (8.5)
4' 157.3 (C)  165.1 (C)  
CH 43.2 (CH) 4.20, m 43.3 (CH) 4.18, m 
 37.3 (CH2) 2.03, m 40.1 (CH2) 3.07, m 
 29.7 (CH2) 2.42, m 27.2 (CH2) 2.86, m 
C   202.0 (C)  
1" 122.6 (C)  124.8 (C)  
2" 152.7 (C) 157.5 (C) 
3" 99.7 (CH) 6.35, s 99.7 (CH) 6.33, s 
4" 157.5 (C)  149.6 (C)  
5" 124.5 (C)  120.7 (C)  
6" 130.1 (CH) 6.68, s 131.2 (CH) 6.76, s 
1"' 139.6 (C)  139.4 (C)  
2"' 130.2 (CH) 7.24, d (8.5) 130.1 (CH) 7.06, d (8.6)
3"' 116.0 (CH) 6.78, d (8.5) 114.3 (CH) 6.68, d (8.6)
4"' 157.3 (C)  155.2 (C)  
5"' 116.0 (CH) 6.78, d (8.5) 114.3 (CH) 6.68, d (8.6)
6"' 130.2 (CH) 7.24, d (8.5) 130.1 (CH) 7.06, d (8.6)
CH' 43.2 (CH) 4.20, m 43.2 (CH) 4.18, m 
' 37.3 (CH2) 2.03, m 37.4 (CH2) 2.06, m 
' 29.7 (CH2) 2.42, m 29.7 (CH2) 2.38, m 
''   37.3 (CH2) 2.06, m 
''   29.7 (CH2) 2.38, m 
1'''' 123.3 (C) 138.4 (C) 
2'''' 159.7 (C)  130.1 (CH) 7.06, d (8.6)
3'''' 126.1 (C)  114.7 (CH) 6.68, d (8.6)
4'''' 158.9 (C)  156.6 (C)  
5'''' 99.8 (CH) 6.24, d (8.5) 114.7 (CH) 6.68, d (8.6)
6'''' 131.1 (CH) 6.72, d (8.5) 130.1 (CH) 7.06, d (8.6)
1''''' 138.5 (C)  125.0 (C)  
2''''' 130.2 (CH) 7.24, d (8.5) 158.9 (C)  
3''''' 116.0 (CH) 6.78, d (8.5) 99.8 (CH) 6.33, s 
4''''' 157.8 (C)  159.7 (C)  
5''''' 116.0 (CH) 6.78, d (8.5) 107.5 (CH) 6.28, d (8.5)
6''''' 130.2 (CH) 7.24, d (8.5) 132.0 (CH) 6.76, d (8.5)
CH3 9.1 (CH3) 1.90, s   
OCH3 55.6 (CH3) 3.72, s 55.6 (CH3) 3.68, s  
OCH3 55.6 (CH3) 3.72, s 55.7 (CH3) 3.72, s 
OCH3 55.8 (CH3) 3.68, s 55.8 (CH3) 3.64, s 
 
Figure 3.  Characteristic EIMS fragments of compound 4 
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Yunnan, China). A sample was deposited in our laboratory. 
Identification of the extract was supported by an HPLC  
comparison with an authentic sample, which was Long-Xue-
Jie (Chinese dragon’s blood, No. 020624) provided by 
Xishuangbanna Botanical Garden, Chinese Academy of  
Sciences. A voucher specimen of D. cochinchinensis (KUN 
0238050) is deposited in State Key Laboratory of Phytochem-
istry and Plant Resources in west China, Kunming Institute of 
Botany, Chinese Academy of Sciences. 
 
Extraction and Isolation. The red resin (1.0 Kg) of D. 
cochinchinensis was extracted with CHCl3, EtOAc, and MeOH, 
successively. The CHCl3 extract (90 g) was subjected to silica 
gel CC and eluted with the following gradient: CHCl3, 
CHCl3/MeOH (20:1, 10:1, 10:2) and finally MeOH, to give 6 
fractions (Fr. 1–6). Fr. 5 (10.0 g) and Fr. 6 (5.0 g) were  
subjected separately to repeated CC on silica gel (CHCl3/MeOH,
20:1–4:1) and Sephadex LH-20 (MeOH) to yield 1 (30 mg), 2 
(32 mg), 3 (7 mg), 6 (cinnabarone, 15 mg), and a mixture (15 
mg) of 7 and 8 from Fr. 5, and 4 (100 mg) and 5 (20 mg) from 
Fr. 6, respectively. 
 
Cochinchinenin D (1): brown amorphous powder; [α] 17D   
+48.8 (c 0.20, MeOH); UV (MeOH) max nm (log ): 206 
(2.48), 280 (2.21); 1H and 13C NMR: see Table 1; EIMS m/z 
542 [M]+; HRESIMS (Positive ion mode) m/z 542.2261 [M]+ 
(calcd for C33H34O7, 542.2304). 
 
Cochinchinenin E (2): brown amorphous powder; [α] 17D   
+33.7 (c 0.30, MeOH). UV (MeOH) max nm (log ): 207 
(2.69), 285 (2.48); 1H and 13C NMR: see Table 1; EIMS m/z 
526 [M]+ (85), 375 (100), 361 (70), 270 (45), 151 (47), 137 
(55), 107 (74), 77 (11); HRESIMS (Positive ion mode) m/z 
526.2346 [M]+ (calcd for C33H34O6, 526.2355). 
 
Cochinchinenin F (3): brown amorphous powder; [α] 17D   
+8.0 (c 0.23, MeOH); UV (MeOH) max nm (log ): 206 (2.60), 
280 (2.58); 1H and 13C NMR: see Table 1; EIMS m/z 542 [M]+; 
HRESIMS (positive ion mode) m/z 542.2303 [M]+ (calcd for 
C33H34O7, 542.2304). 
 
Cochinchinenin G (4): brown amorphous powder; UV 
(MeOH) max nm (log ): 207 (2.69), 285 (2.21); 1H and 13C 
NMR: see Table 2; FABMS (negative ion mode) m/z 781 [M – 
H]–; HRFABMS (negative ion mode) m/z 781.3367 [M – H]– 
(calcd for C49H49O9, 781.3376).  
 
Cochinchinenin H (5): brown amorphous powder; [α]17D   
+5.1 (c 0.23, MeOH). UV (MeOH) max nm (log ): 207 (2.69), 
285 (2.58); 1H and 13C NMR: see Table 2; FABMS (negative 
ion mode) m/z 811 [M – H]–; HRFABMS (negative mode) m/z 
811.3450 [M – H]– (calcd for C50H51O10, 811.3482). 
 
Cytotoxicity (Cdc25) Assay. The cytotoxicity activity of 
the pure compounds against Cdc25 was determined using the 
method described previously.39 
 
Antibacterial (PEPT) Assay. The assay employed is a 
microtiterplate adaptation of a phosphate detection method 
described previously.40 
 
Antifungal (YNG) Assay. The assay was performed as  
described previously.41 
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